Skip to content

To test the effect of abhirumuladhi herbal drug in mentally unstable children

A clinical evaluation of abhirumuladi avaleha in the management of autism spectrum disorder (ASD) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109467
Enrollment
15
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F808- Other developmental disorders of speech and language

Interventions

None listed

Sponsors

Shri Babu Singh Jay Singh Ayurvediuc Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with and presenting complaints of Autism will be taken. 2. Mild to moderate autistic patients will be taken. 3.From the age group of 5 to 16 years of subjects irrespective of gender, caste, socioeconomic status and food habits will be taken. 4.Parents/ guardian willing to give informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: 1.Children below 5 years and above 16 years. 2.Severe Autistic Patients. 3.Hearing and visual impairment, Multiple disabilities. 4.Patients with acute and chronic systemic illness such as renal diseases, Hepatic dysfunction, Juvenile diabetes mellitus, malignancy, etc. 5.Progressive and non-progressive neuromuscular disorders, Known neurodegenerative disorder, Cerebral palsy. 6.Children taking anti-epileptic and anti-psychotic drugs

Design outcomes

Primary

MeasureTime frame
work on Hyperactivity, Aggressiveness, And ConcentrationTimepoint: 45 DAYS

Secondary

MeasureTime frame
IT WILL IMPROVE QUALITY OF LIFE OF AUTISTIC CHILDRENTimepoint: 45 DAYS

Countries

India

Contacts

Public ContactDr Jasmine

Desh Bhagat University, Mandi Gobindgarh, Punjab

dahiya.darshana222@yahoo.com8607507594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026